| 词条 | AveXis |
| 释义 |
| name = AveXis | logo = AveXis.svg | type = | industry = Biotechnology, Pharmaceutical | fate = | traded_as = | predecessor = | successor = | founded = | founders = | defunct = | hq_location_city = Chicago | hq_location_country = United States of America | area_served = | key_people = | products = | owner = | num_employees = | num_employees_year = | parent = Novartis | website = {{URL|www.avexis.com}} }}AveXis is a biotechnology company whose drug pipeline includes gene therapy preparations for rare neurological genetic disorders, the most advanced one being onasemnogene abeparvovec (AVXS-101) for spinal muscular atrophy (SMA).[1] AveXis was acquired by Novartis in 2018.[2][3][4][5][6][7][8] References1. ^{{cite news|url=https://www.sciencemag.org/news/2017/11/gene-therapy-s-new-hope-neuron-targeting-virus-saving-infant-lives|title=Gene therapy’s new hope: A neuron-targeting virus is saving infant lives|last=Kaiser|first=Kaiser|date=1 November 2017|work=Science|access-date=10 January 2018|location=}} {{Company-stub}}2. ^{{cite news |last=Herper|first=Mathew|date=19 December 2018|title=A Year In, Novartis’ Boss Faces The World|url=https://www.forbes.com/sites/matthewherper/2018/12/19/a-year-in-novartis-boss-faces-the-world/|work=Forbes|location= |access-date=10 January 2018}} 3. ^{{cite news |last=Delclaux|first=Alberto|date=9 April 2018|title=Novartis Bets $8.7 Billion on Gene-Therapy Company|url=https://www.wsj.com/articles/novartis-to-buy-gene-therapy-company-avexis-for-8-7-billion-1523251511|work=The Wall Street Journal|location= |access-date=10 January 2018}} 4. ^{{cite news |last=Rose|first=Marla|date=9 April 2018|title=Gene-therapy company with research ties to Columbus sold to Novartis for $8.7 billion|url=https://www.dispatch.com/business/20180409/gene-therapy-company-with-research-ties-to-columbus-sold-to-novartis-for-87-billion|work=The Columbus Dispatch|location= |access-date=10 January 2018}} 5. ^{{cite news |last=Miller|first=John|date=9 April 2018|title=Novartis bets big on gene therapy with $8.7 billion AveXis deal|url=https://ca.reuters.com/article/businessNews/idCAKBN1HG0FT-OCABS|work=Reuters|location= |access-date=10 January 2018}} 6. ^{{cite news |last=Kresge|first=Naomi|date=9 April 2018|title=Novartis Wager on AveXis Shows Rare Diseases Command Mega Prices|url=https://www.bloomberg.com/news/articles/2018-04-09/rare-diseases-command-mega-prices-with-novartis-wager-on-avexis|work=Bloomberg News|location= |access-date=10 January 2018}} 7. ^{{cite news |last=Kresge|first=Naomi|date=9 April 2018|title=Novartis CEO Spurs Rare-Disease Shift With $8.7 Billion Deal|url=https://www.bloomberg.com/news/articles/2018-04-09/novartis-to-pay-8-7-billion-for-gene-therapy-company-avexis|work=Bloomberg News|location= |access-date=10 January 2018}} 8. ^{{cite news |last=Woodyard|first=Chris|date=9 April 2018|title=Novartis buying AveXis for $8.7B in big gene therapy bet|url=https://www.usatoday.com/story/money/business/2018/04/09/novartis-buying-gene-therapy-company-avexis-8-7-billion/498137002/|work=USA Today|location= |access-date=10 January 2018}} 3 : Pharmaceutical companies of the United States|Biotechnology companies of the United States|Spinal muscular atrophy |
| 随便看 |
|
开放百科全书收录14589846条英语、德语、日语等多语种百科知识，基本涵盖了大多数领域的百科知识，是一部内容自由、开放的电子版国际百科全书。